Journal News

A jellyfish model to study optogenetics

Adenike Shittu
By Adenike Shittu
Dec. 26, 2023

Box jellyfish, an ancient invertebrate species, have evolved separately from vertebrate animals for over 500 million years. Unlike other jellyfish species, box jellyfish have well-developed eyes similar to those of vertebrates. These eyes have a light-sensitive protein receptor called rhodopsin that enables them to process visual cues such as twilight and color perception, which are essential for their survival.

Shino Inukai, Kota Katayama, Hideki Kandori and colleagues at the Nagoya Institute of Technology in Japan have found that the rhodopsin in jellyfish is similar to that in vertebrates. In a recent article published in the Journal of Biological Chemistry, they describe the structural similarities, photoreaction activity and highly developed visual function of rhodopsin in box jellyfish and vertebrates.

Box jellyfish have the only animal rhodopsin known to activate Gs protein. G proteins are guanine nucleotide-binding proteins. They can transmit signals from receptors on the cell surface to the inside of the cell, where they regulate a wide range of cellular functions and processes. These include maintenance of cellular homeostasis, response to external stimuli, neurotransmission and sensory perception.

Box jellyfish’s rhodopsin, or JelRh, is the only animal rhodopsin that researchers have shown to transduce the G protein signaling pathways. Because jellyfish rhodopsin can control the G proteins’ signaling pathway with light, it is a promising new optogenetics tool.

The authors used JelRh to study how G proteins regulate cyclic adenosine monophosphate induction, or cAMP, which is widely associated with biological processes such as circadian rhythms, cardiac function and behavioral control. In the words of the authors, “the development of jellyfish rhodopsin can be used as a tool to elucidate the molecular mechanisms of diseases caused by abnormal signal transduction through Gs protein,” which include nephrogenic diabetes insipidus and obesity.

While this study shows promising findings, the authors acknowledge certain limitations in this model. The authors’ discovery of JelRh’s distinctive hydrogen bonding network surrounding the retinal chromophore hints at intermediate structural variance in rhodopsin in other invertebrates and vertebrates.

Researchers have not yet characterized other essential defining factors of JelRh. Therefore, as a future work, the authors propose to conduct site-directed mutation measurements to determine the key residues, in GPCR activation. Future structural studies will focus on the photoreaction of the active state to explore how JelRh triggers Gs protein–mediated phototransduction cascade. Specifically, the spectroscopy-based structural study of photoreaction dynamics of Gs-coupled animal rhodopsin will provide insights into the activation mechanism of G protein–coupled receptors.

Looking forward, the team proposes to clarify the light activation and signal transduction mechanisms of JelRh, the only animal rhodopsin that has been shown to transduce Gs signal. Specifically, the aim is to decipher the molecular intricacies underlying the activation of Gs protein.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Adenike Shittu
Adenike Shittu

Adenike Shittu is a biomedi­cal research scientist who is passionate about science communication and an ASBMB Today contributing writer.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.